Protein Molecular Characteristics and Prognosis of Cervical Neuroendocrine Tumors
Trial Parameters
Brief Summary
The clinical diagnosis and treatment data of 300 cases of cervical neuroendocrine tumors were collected, including age, preoperative biopsy pathology results, postoperative histopathological results, TCT results, and colposcopy biopsy pathology results. At the same time, paraffin tissue specimens (remaining specimens after pathological diagnosis) from 100 cases of cervical neuroendocrine tumors from multiple centers across the country were collected to establish a cervical neuroendocrine tumor data follow-up database. Protein concentration and omics analysis were performed on the data results, to evaluate the molecular characteristics and prognosis of cervical neuroendocrine tumor proteins, and to preliminarily explore its clinical application value.
Eligibility Criteria
Inclusion Criteria: 1. Patients diagnosed with cervical neuroendocrine carcinoma by histopathology 2. Clinical data were complete Exclusion Criteria: 1. Patients who are not being treated in our hospital 2. Patients with lack of follow-up data, unable to obtain survival information 3. Patients call to refuse to participate in this project 4. The quality of paraffin specimens can not meet the requirements of proteome concentration determination